2015 Aug 19 - Elucidating tumor heterogeneity in prostate cancer by combined IHC & novel RNA ISH
Nallasivam Palanisamy
PhD | Associate Scientist, Department of Urology Henry Ford Health System, Detroit, MI
Watch Video:

Assessment of molecular heterogeneity in tumor is a challenging task. Palanisamy et al are the first to demonstrate the novel detection of a rare subset of prostate cancer with heterogeneous molecular aberrations involving ETS family genes and SPINK1 expression utilizing both standard immunohistochemistry (IHC) and RNA in situ hybridization (Advanced Cell Diagnostics RNAscope™ Technology). The presenter will discuss the application of RNA ISH technology to reveal previously unidentified molecular subtypes of prostate cancer.

Publications to be discussed:

1. Kunju LP, Carskadon S, Siddiqui J, Tomlins SA, Chinnaiyan AM, Palanisamy N.(2014) Novel RNA hybridization method for the in situ detection of ETV1, ETV4, and ETV5 gene fusions in prostate cancer. Appl Immunohistochem Mol Morphol. 2014 Sep;22(8):e32-40. doi: 10.1097/PAI.0000000000000095.

2. Joshua I Warrick, Scott A Tomlins, Shannon L Carskadon, Allison M Young,Javed Siddiqui, John T Wei, Arul M Chinnaiyan, Lakshmi P Kunju, and Nallasivam Palanisamy Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization— a correlative study with urine PCA3 and TMPRSS2-ERG Modern Pathology (2014) 27, 609–620

Who should attend:

Cancer researchers, pathologists, histologists interested in understanding new molecular techniques to:

  • Uncover intra-tumoral heterogeneity
  • Understand how measuring RNA expression can uncover details of tumor microenvironments
  • Understand cell-specific expression information
  • Visualize RNA targets in the full context of tissue architecture and/or measure regional RNA distribution
  • Quantify expression of coding and non-coding RNA including pseudogenes
Learning Objectives:
  • How RNAscope technology can be used in cancer research
  • How RNAscope technology delivers quantitative molecular detection and morphological context in a single assay
  • Ease of using the highly sensitive and specific assay for virtually any gene in any tissue
  • Advantages of RNAscope technology vs. other ISH and IHC methods

Download Presentation

Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798



19 Barton Lane  
Abingdon Science Park
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420


Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com